Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Cipla Gears To Step In With Gx Kaletra Supplies For nCoV

Thu, 01/30/2020 - 12:30am

Over half a dozen generic versions of AbbVie's Kaletra, currently part of treatment guidelines in China for nCoV-2019, are already...

      Related Stories 

China Compensates Physicians Ahead Of WHO Global Emergency Decision

Wed, 01/29/2020 - 11:59pm

China continues to battle coronavirus outbreak with cases now rising above 7,000 ahead of a decision by the WHO whether...

      Related Stories 

China Coronavirus Cases Up Sharply As Pharma Rushes To Aid

Wed, 01/29/2020 - 5:01pm

AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert...

      Related Stories 

Deal Watch: Conatus Ends NASH Ambitions, Merges With Regenerative Medicine Firm Histogen

Wed, 01/29/2020 - 12:43pm

Reverse merger takes Histogen public as it seeks mid-stage data for male pattern baldness by end of 2020. AstraZeneca continues...

      Related Stories 

Sumitovant Keeping Sumitomo Dainippon-Acquired Roivant Companies On Track

Wed, 01/29/2020 - 9:23am

Scrip spoke with Sumitovant CEO Myrtle Potter about short- and long-term goals for the portfolio of five companies, including Myovant...

      Related Stories 

Atriva Fast Tracks Anti-Viral Candidate As Coronavirus Arrives In Germany

Wed, 01/29/2020 - 7:18am

The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.

      Related Stories 

Zolgensma Stands Out In Strong Q4 For Novartis

Wed, 01/29/2020 - 6:57am

CEO Vas Narasimhan is confident the Swiss major's gene therapy for spinal muscular atrophy will outperform present and future rivals...

      Related Stories 

Dr Reddy’s Posts Surprise Q3 Loss But Strong Operating Results Boost Shares

Tue, 01/28/2020 - 6:37pm

Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge for its generic NuvaRing contraceptive...

      Related Stories 

Pfizer’s Biosimilar Strategy Might Be Working

Tue, 01/28/2020 - 11:40am

Pfizer's biosimilar franchise  is well on its way to becoming a blockbuster business three years after the company launched its...

      Related Stories 

Surprise! Pfizer And Lilly File Tanezumab For Pain With FDA Despite Safety Questions

Tue, 01/28/2020 - 11:30am

The partners have filed the first-in-class NGF inhibitor at the lower 2.5mg dose for the treatment of osteoarthritis pain, despite...

      Related Stories 

Acceleron Buoyed By Sotatercept’s Promise In PAH

Tue, 01/28/2020 - 6:03am

Top-line Phase II results from the PULSAR study suggest Acceleron’s sotatercept is effective as add-on treatment for patients with PAH...

      Related Stories 

AZ Gets IBD Drug Back From Allergan

Mon, 01/27/2020 - 11:42pm

Allergan is selling its Crohn’s disease and ulcerative colitis drug brazikumab back to AstraZeneca to satisfy regulators ahead of its...

      Related Stories 

Hilleman CEO Moving On, Hands Baton To Ex-Takeda Executive

Mon, 01/27/2020 - 11:37pm

Hilleman CEO Davinder Gill is leaving the global vaccine R&D organization after eight years at the helm and several mileposts...

      Related Stories